Pharmaceutical ingredient manufacturer Antheia announced today that it completed a second close of its Series C financing. The company added $24 million to the Series C round, bringing the total round to $80 million. It announced the first close of $56 million in funding in June 2025. Combined with additional capital and non-dilutive funding, including through…
Pharma ingredient manufacturer Antheia raises $56M Series C
Pharmaceutical ingredient manufacturer Antheia announced today that it raised $56 million in Series C financing. The Menlo Park, California-based company aims to deliver ingredients to transform essential medicine supply chains. It plans to use the financing to expand the commercialization of its first product, Thebaine. The company also plans to launch additional products from its…